Business
Site visit
Site visit.
About this update from Ilika Plc
[{"type":"text","content":"\n \nRNS Number : 2329R Ilika plc 28 October 2019 \n\nIlika plc\n(\"Ilika\" or the \"Company\")\n \nSite visit\n \nIlika (AIM: IKA), a pioneer in solid-state battery technology, will be hosting a site visit at the Company's headquarters in Romsey, Hampshire for investors and analysts on Thursday 5 December 2019.\n \nThe event will provide an opportunity to meet the Senior Management team, take a tour of the recently opened large format battery facility and hear presentations from both the Company and sector specific analysts focused on the battery industry. Two sessions will be hosted, one in the morning welcoming analysts and institutional investors and one in the afternoon welcoming private investors.\n \nAll attendees must register through Walbrook PR to reserve a space. For more information and to register, please email [email protected] or telephone Walbrook PR on the number below.\n \nThe presentation made at the site visit will be made available on the Company's website to download along with a video of the presentation: https://www.ilika.com/investors\n \nNo new material information regarding current trading will be disclosed at the site visit. \n \n \n \nFor more information contact:\n \n\n\n\n\nIlika plc\n\n\n \n\n\n\n\nGraeme Purdy, Chief Executive\n\n\nTel: 023 8011 1400\n\n\n\n\nSteve Boydell, Finance Director\n\n\n \n\n\n\n\n \n\n\n \n\n\n\n\nLiberum Capital Limited\n\n\nTel: 020 3100 2000\n\n\n\n\nAndrew Godber, Cameron Duncan, William Hall\n\n\n \n\n\n\n\n \n\n\n \n\n\n\n\nWalbrook PR Ltd \n\n\nTel: 020 7933 8780 / [email protected]\n\n\n\n\nLianne Cawthorne \n\n\nMob: 07584 391 303\n\n\n\n\nNick Rome\n\n\nMob: 07748 325 236\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com. END NRAEAKESAFSNFFF\n ","length":5991,"tagName":"div"}]